These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 35027728)

  • 1. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.
    Phetsouphanh C; Darley DR; Wilson DB; Howe A; Munier CML; Patel SK; Juno JA; Burrell LM; Kent SJ; Dore GJ; Kelleher AD; Matthews GV
    Nat Immunol; 2022 Feb; 23(2):210-216. PubMed ID: 35027728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.
    Contoli M; Papi A; Tomassetti L; Rizzo P; Vieceli Dalla Sega F; Fortini F; Torsani F; Morandi L; Ronzoni L; Zucchetti O; Pavasini R; Fogagnolo A; Volta CA; Bartlett NW; Johnston SL; Spadaro S; Campo G
    Front Immunol; 2021; 12():648004. PubMed ID: 33767713
    [No Abstract]   [Full Text] [Related]  

  • 3. Age-Related Expression of IFN-λ1
    Gilbert C; Lefeuvre C; Preisser L; Pivert A; Soleti R; Blanchard S; Delneste Y; Ducancelle A; Couez D; Jeannin P
    Front Immunol; 2021; 12():750279. PubMed ID: 34858406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.
    Ansari A; Arya R; Sachan S; Jha SN; Kalia A; Lall A; Sette A; Grifoni A; Weiskopf D; Coshic P; Sharma A; Gupta N
    Front Immunol; 2021; 12():636768. PubMed ID: 33777028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19.
    You M; Chen L; Zhang D; Zhao P; Chen Z; Qin EQ; Gao Y; Davis MM; Yang P
    Nat Cell Biol; 2021 Jun; 23(6):620-630. PubMed ID: 34108657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning.
    Patterson BK; Guevara-Coto J; Yogendra R; Francisco EB; Long E; Pise A; Rodrigues H; Parikh P; Mora J; Mora-Rodríguez RA
    Front Immunol; 2021; 12():700782. PubMed ID: 34262570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
    Liou TG; Adler FR; Cahill BC; Cox DR; Cox JE; Grant GJ; Hanson KE; Hartsell SC; Hatton ND; Helms MN; Jensen JL; Kartsonaki C; Li Y; Leung DT; Marvin JE; Middleton EA; Osburn-Staker SM; Packer KA; Shakir SM; Sturrock AB; Tardif KD; Warren KJ; Waddoups LJ; Weaver LJ; Zimmerman E; Paine R
    Physiol Rep; 2021 Feb; 9(4):e14761. PubMed ID: 33625796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections.
    Kennedy AE; Cook L; Breznik JA; Cowbrough B; Wallace JG; Huynh A; Smith JW; Son K; Stacey H; Ang J; McGeer A; Coleman BL; Larché M; Larché M; Hambly N; Nair P; Ask K; Miller MS; Bramson J; Levings MK; Nazy I; Svenningsen S; Mukherjee M; Bowdish DME
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.
    Ruenjaiman V; Hirankarn N; Palaga T
    Asian Pac J Allergy Immunol; 2021 Jun; 39(2):69-77. PubMed ID: 34174806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma.
    Aleman A; Upadhyaya B; Tuballes K; Kappes K; Gleason CR; Beach K; Agte S; Srivastava K; ; Van Oekelen O; Barcessat V; Bhardwaj N; Kim-Schulze S; Gnjatic S; Brown B; Cordon-Cardo C; Krammer F; Merad M; Jagannath S; Wajnberg A; Simon V; Parekh S
    Cancer Cell; 2021 Nov; 39(11):1442-1444. PubMed ID: 34706273
    [No Abstract]   [Full Text] [Related]  

  • 12. The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes.
    Tang G; Huang M; Luo Y; Liu W; Lin Q; Mao L; Wu S; Xiong Z; Hou H; Sun Z; Wang F
    Front Immunol; 2021; 12():697622. PubMed ID: 34777333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
    Rodda LB; Netland J; Shehata L; Pruner KB; Morawski PA; Thouvenel CD; Takehara KK; Eggenberger J; Hemann EA; Waterman HR; Fahning ML; Chen Y; Hale M; Rathe J; Stokes C; Wrenn S; Fiala B; Carter L; Hamerman JA; King NP; Gale M; Campbell DJ; Rawlings DJ; Pepper M
    Cell; 2021 Jan; 184(1):169-183.e17. PubMed ID: 33296701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Kang CK; Kim M; Lee S; Kim G; Choe PG; Park WB; Kim NJ; Lee CH; Kim IS; Jung K; Lee DS; Shin HM; Kim HR; Oh MD
    J Infect Dis; 2021 Jul; 224(1):39-48. PubMed ID: 33755725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms.
    Livanos AE; Jha D; Cossarini F; Gonzalez-Reiche AS; Tokuyama M; Aydillo T; Parigi TL; Ladinsky MS; Ramos I; Dunleavy K; Lee B; Dixon RE; Chen ST; Martinez-Delgado G; Nagula S; Bruce EA; Ko HM; Glicksberg BS; Nadkarni G; Pujadas E; Reidy J; Naymagon S; Grinspan A; Ahmad J; Tankelevich M; Bram Y; Gordon R; Sharma K; Houldsworth J; Britton GJ; Chen-Liaw A; Spindler MP; Plitt T; Wang P; Cerutti A; Faith JJ; Colombel JF; Kenigsberg E; Argmann C; Merad M; Gnjatic S; Harpaz N; Danese S; Cordon-Cardo C; Rahman A; Schwartz RE; Kumta NA; Aghemo A; Bjorkman PJ; Petralia F; van Bakel H; Garcia-Sastre A; Mehandru S
    Gastroenterology; 2021 Jun; 160(7):2435-2450.e34. PubMed ID: 33676971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity.
    Fang H; Wegman AD; Ripich K; Friberg H; Currier JR; Thomas SJ; Endy TP; Waickman AT
    Viruses; 2021 May; 13(5):. PubMed ID: 34063463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology of SARS-CoV-2 infection in children.
    Chou J; Thomas PG; Randolph AG
    Nat Immunol; 2022 Feb; 23(2):177-185. PubMed ID: 35105983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in immune responses that underlie COVID-19 disease outcomes.
    Takahashi T; Ellingson MK; Wong P; Israelow B; Lucas C; Klein J; Silva J; Mao T; Oh JE; Tokuyama M; Lu P; Venkataraman A; Park A; Liu F; Meir A; Sun J; Wang EY; Casanovas-Massana A; Wyllie AL; Vogels CBF; Earnest R; Lapidus S; Ott IM; Moore AJ; ; Shaw A; Fournier JB; Odio CD; Farhadian S; Dela Cruz C; Grubaugh ND; Schulz WL; Ring AM; Ko AI; Omer SB; Iwasaki A
    Nature; 2020 Dec; 588(7837):315-320. PubMed ID: 32846427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19.
    Aguilar-Bretones M; Westerhuis BM; Raadsen MP; de Bruin E; Chandler FD; Okba NM; Haagmans BL; Langerak T; Endeman H; van den Akker JP; Gommers DA; van Gorp EC; GeurtsvanKessel CH; de Vries RD; Fouchier RA; Rockx BH; Koopmans MP; van Nierop GP
    J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34499051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.